Kaposi's Sarcoma Cells of Different Etiologic Origins Respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): Relevance in AIDS-KS Pathology
- 24 June 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 273 (1) , 267-271
- https://doi.org/10.1006/bbrc.2000.2941
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi‚s sarcomaAIDS, 1999
- Kaposi's Sarcoma-Associated HerpesvirusPublished by Elsevier ,1998
- Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.Journal of Clinical Investigation, 1995
- Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma.Proceedings of the National Academy of Sciences, 1994
- TGFβ and FGF-like growth factors involved in the pathogenesis of AIDS-associated Kaposi's sarcomaResearch in Virology, 1993
- Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance.Proceedings of the National Academy of Sciences, 1992
- Oncostatin M as a Potent Mitogen for AIDS-Kaposi's Sarcoma-Derived CellsScience, 1992
- AIDS-Kaposi's Sarcoma-Derived Cells Express Cytokines with Autocrine and Paracrine Growth EffectsScience, 1989
- A Review of Kaposi's SarcomaAdvances in Cancer Research, 1989
- Invasive activity and chemotactic response to growth factors by Kaposi's sarcoma cellsJournal of Cellular Biochemistry, 1988